Common use of Reverse Split Clause in Contracts

Reverse Split. The Company has taken all necessary corporate action to effectuate a reverse split of its issued and outstanding Common Stock and preferred stock on the basis of one (1) such share for each 2.67 shares of issued and outstanding Common Stock and Preferred Stock, as applicable (the “Reverse Split”), and such Reverse Split became effective on June 22, 2020.

Appears in 3 contracts

Sources: Underwriting Agreement (Greenwich LifeSciences, Inc.), Underwriting Agreement (Greenwich LifeSciences, Inc.), Underwriting Agreement (Greenwich LifeSciences, Inc.)

Reverse Split. The Company has taken all necessary corporate action to effectuate a reverse split of its issued and outstanding Common Stock and preferred stock on the basis of one (1) such share for each 2.67 6 shares of issued and outstanding Common Stock and Preferred Stock, as applicable (the “Reverse Split”), and such Reverse Split became effective on June 22[*], 2020.

Appears in 2 contracts

Sources: Underwriting Agreement (Lixte Biotechnology Holdings, Inc.), Underwriting Agreement (Lixte Biotechnology Holdings, Inc.)

Reverse Split. The Company has taken all necessary corporate action to effectuate a reverse split of its issued and outstanding Common Stock and preferred stock on the basis of one (1) such share for each 2.67 2.5 shares of issued and outstanding Common Stock and Preferred Stock, as applicable (the “Reverse Split”), and such Reverse Split became effective on June 22on[____], 20202021.

Appears in 1 contract

Sources: Underwriting Agreement (Bone Biologics Corp)

Reverse Split. The Company has taken all necessary corporate action to effectuate a reverse split of its issued and outstanding Common Stock and preferred stock on the basis of one (1) such share for each 2.67 2.5 shares of issued and outstanding Common Stock and Preferred Stock, as applicable (the “Reverse Split”), and such Reverse Split became effective on June 22October 12, 20202021.

Appears in 1 contract

Sources: Underwriting Agreement (Bone Biologics Corp)

Reverse Split. The Company has taken all necessary corporate action to effectuate a reverse split of its issued and outstanding Common Stock and preferred stock on the basis of one (1) such share for each 2.67 6 shares of issued and outstanding Common Stock and Preferred Stockpreferred stock, as applicable (the “Reverse Split”), and such Reverse Split became effective on June 22November 20, 2020.

Appears in 1 contract

Sources: Underwriting Agreement (Lixte Biotechnology Holdings, Inc.)